PCRX
Pacira BioSciences Inc

1,562
Mkt Cap
$1.04B
Volume
1,458.00
52W High
$27.64
52W Low
$18.17
PE Ratio
54.23
PCRX Fundamentals
Price
$24.19
Prev Close
$24.07
Open
$24.74
50D MA
$23.23
Beta
0.41
Avg. Volume
803,988.68
EPS (Annual)
-$2.15
P/B
1.43
Rev/Employee
$887,298.73
Loading...
Loading...
News
all
press releases
PCRX's Iovera Outperforms RFA Therapy in Pilot Study for Low Back Pain
Pacira BioSciences' iovera shows stronger, longer-lasting relief than RFA in a pilot CLBP study, highlighting its tissue-sparing approach and potential spine-care impact.
Zacks·19h ago
News Placeholder
More News
News Placeholder
PCRX's Iovera Outperforms RFA Therapy in Pilot Study for Low Back Pain
Pacira BioSciences' iovera shows stronger, longer-lasting relief than RFA in a pilot CLBP study, highlighting its tissue-sparing approach and potential spine-care impact.
Zacks·19h ago
News Placeholder
PCRX's Iovera Outperforms RFA Therapy in Pilot Study for Low Back Pain
Pacira BioSciences' iovera shows stronger, longer-lasting relief than RFA in a pilot CLBP study, highlighting its tissue-sparing approach and potential spine-care impact.
Zacks·19h ago
News Placeholder
LSV Asset Management Has $2.28 Million Stake in Pacira BioSciences, Inc. $PCRX
LSV Asset Management grew its position in Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 16.0% in the second quarter, according to its most recent Form 13F filing with the Securities and...
MarketBeat·12d ago
News Placeholder
Pacira BioSciences, Inc. $PCRX Shares Sold by Bank of Montreal Can
Bank of Montreal Can reduced its stake in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 65.1% during the 2nd quarter, according to its most recent filing with the SEC. The firm...
MarketBeat·13d ago
News Placeholder
Insider Selling: Pacira BioSciences (NASDAQ:PCRX) Insider Sells 3,960 Shares of Stock
Pacira BioSciences, Inc. (NASDAQ:PCRX - Get Free Report) insider Jonathan Slonin sold 3,960 shares of the firm's stock in a transaction that occurred on Monday, November 17th. The stock was sold at...
MarketBeat·13d ago
News Placeholder
Integrated Quantitative Investments LLC Sells 28,621 Shares of Pacira BioSciences, Inc. $PCRX
Integrated Quantitative Investments LLC lessened its position in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 73.4% in the second quarter, according to its most recent filing...
MarketBeat·15d ago
News Placeholder
Los Angeles Capital Management LLC Sells 41,645 Shares of Pacira BioSciences, Inc. $PCRX
Los Angeles Capital Management LLC lessened its stake in Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 78.4% during the 2nd quarter, according to its most recent disclosure with the...
MarketBeat·16d ago
News Placeholder
Pacira BioSciences, Inc. (NASDAQ:PCRX) Given Average Recommendation of "Hold" by Brokerages
Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX - Get Free Report) have been given a consensus rating of "Hold" by the seven brokerages that are currently covering the company, MarketBeat.com...
MarketBeat·18d ago
News Placeholder
Impax Asset Management Group plc Trims Stake in Pacira BioSciences, Inc. $PCRX
Impax Asset Management Group plc lowered its position in Pacira BioSciences, Inc. (NASDAQ:PCRX - Free Report) by 13.0% in the 2nd quarter, according to the company in its most recent disclosure with...
MarketBeat·19d ago

Latest PCRX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.